Skip to Main Content (Press Enter)

Logo CNR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Strutture
  • Competenze

UNI-FIND
Logo CNR

|

UNI-FIND

cnr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Strutture
  • Competenze
  1. Pubblicazioni

Effects of TNF-alpha/colchicine combined treatment on Burkitt lymphoma cells: Molecular and ultrastructural changes

Articolo
Data di Pubblicazione:
1999
Abstract:
Tumour necrosis factor alpha (TNF-alpha) kills Daudi cells (Human Burkitt Lymphoma), inducing either necrosis or apoptosis without DNA fragmentation. Therefore, we were interested in studying the molecular and ultrastructural events occurring when the nucleus is more accessible and cells are blocked in mitosis, following colchicine treatment. In fact, as early as after 1 h treatment a typical ladder pattern was shown by means of DNA gel electrophoresis. In parallel, the quantitative analysis of the different morphological patterns observed gave evidence of an increased percentage of primary necrosis after 6 h treatment, and a higher incidence of cells in late apoptosis as well as in secondary necrosis after 24 h treatment. Our findings show that Daudi cells respond to the combined treatment with an increased formation of micronuclei and nuclear alterations which follow a number of early mitochondrial changes and result in enhanced cell death. These data imply that, TNF-alpha-induced apoptosis of Daudi cells can be triggered by mitochondrial changes and is somehow related to microtubule organization.
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
Burkitt lymphoma cells; colchicine; Daudi cells; TNF-alpha
Elenco autori:
Robuffo, Iole; Bosco, Domenico
Autori di Ateneo:
ROBUFFO IOLE
Link alla scheda completa:
https://iris.cnr.it/handle/20.500.14243/237419
Pubblicato in:
CYTOKINE
Journal
  • Dati Generali

Dati Generali

URL

http://www.sciencedirect.com/science/article/pii/S1043466698904069
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0 | Sorgente dati: PREPROD (Ribaltamento disabilitato)